2 unknown, 1 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 2, Withdrawn 1 |
Follow urapidil: new trials by email Literature Review of urapidil trials Research Report on urapidil
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hemodynamic Optimization of Cerebral Perfusion After Endovascular Therapy in Patients With Acute Ischemic Stroke Adjusted medication - Acute Ischemic Stroke | Phase 4 | Unknown | Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau | 814 | 2021-06-01 | 2023-03-16 |
| TCD Monitoring Technology Guides the Precise Control of Blood Pressure After EVT Urapidil Hydrochloride Injection - Acute Ischemic Stroke | Phase 4 | Unknown | Xuanwu Hospital, Beijing | 90 | 2018-04-08 | 2018-05-18 |
| Clevidipine (Cleviprex®) Compared With Urapidil (Ebrantil®) Clevidipine, Urapidil - Nontraumatic Intracerebral Hemorrhage, Multiple Localized | Phase 4 | Withdrawn | University of Zurich | 2017-06-15 | 2021-11-08 |
Ischemic Stroke (2)
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau (1) · University of Zurich (1) · Xuanwu Hospital, Beijing (1)
China (1) · Spain (1) · Switzerland (1)
2017 (1)